nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—Topotecan—ovarian cancer	0.0596	0.272	CbGbCtD
Guanfacine—CYP2C9—Paclitaxel—ovarian cancer	0.0507	0.232	CbGbCtD
Guanfacine—CYP3A4—Vinorelbine—ovarian cancer	0.042	0.192	CbGbCtD
Guanfacine—CYP3A4—Paclitaxel—ovarian cancer	0.0295	0.135	CbGbCtD
Guanfacine—CYP3A4—Docetaxel—ovarian cancer	0.0213	0.0974	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—ovarian cancer	0.0159	0.0726	CbGbCtD
Guanfacine—NISCH—Paclitaxel—Docetaxel—ovarian cancer	0.0135	0.446	CbGdCrCtD
Guanfacine—NISCH—Vincristine—Vinorelbine—ovarian cancer	0.00929	0.307	CbGdCrCtD
Guanfacine—NISCH—Vinblastine—Vinorelbine—ovarian cancer	0.00747	0.247	CbGdCrCtD
Guanfacine—Diclofenac—CXCL8—ovarian cancer	0.00669	0.801	CrCbGaD
Guanfacine—NISCH—uterine cervix—ovarian cancer	0.00327	0.1	CbGeAlD
Guanfacine—NISCH—decidua—ovarian cancer	0.00312	0.0954	CbGeAlD
Guanfacine—NISCH—uterus—ovarian cancer	0.00273	0.0834	CbGeAlD
Guanfacine—NISCH—bone marrow—ovarian cancer	0.00232	0.0708	CbGeAlD
Guanfacine—NISCH—female gonad—ovarian cancer	0.00223	0.0682	CbGeAlD
Guanfacine—NISCH—vagina—ovarian cancer	0.00222	0.0678	CbGeAlD
Guanfacine—NISCH—testis—ovarian cancer	0.00198	0.0605	CbGeAlD
Guanfacine—Diclofenac—ABCB1—ovarian cancer	0.00166	0.199	CrCbGaD
Guanfacine—ADRA2A—myometrium—ovarian cancer	0.00153	0.0469	CbGeAlD
Guanfacine—NISCH—lymph node—ovarian cancer	0.00144	0.0439	CbGeAlD
Guanfacine—Renal failure acute—Doxorubicin—ovarian cancer	0.00141	0.00199	CcSEcCtD
Guanfacine—Diarrhoea—Melphalan—ovarian cancer	0.00141	0.00199	CcSEcCtD
Guanfacine—Pain in extremity—Epirubicin—ovarian cancer	0.00141	0.00198	CcSEcCtD
Guanfacine—Nausea—Chlorambucil—ovarian cancer	0.0014	0.00198	CcSEcCtD
Guanfacine—Vision blurred—Paclitaxel—ovarian cancer	0.0014	0.00197	CcSEcCtD
Guanfacine—Visual impairment—Docetaxel—ovarian cancer	0.00139	0.00196	CcSEcCtD
Guanfacine—Dizziness—Topotecan—ovarian cancer	0.00139	0.00196	CcSEcCtD
Guanfacine—Tremor—Paclitaxel—ovarian cancer	0.00139	0.00196	CcSEcCtD
Guanfacine—Affect lability—Epirubicin—ovarian cancer	0.00139	0.00195	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00138	0.00195	CcSEcCtD
Guanfacine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00138	0.00194	CcSEcCtD
Guanfacine—Agitation—Paclitaxel—ovarian cancer	0.00136	0.00192	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—ovarian cancer	0.00135	0.00191	CcSEcCtD
Guanfacine—Eye disorder—Docetaxel—ovarian cancer	0.00135	0.0019	CcSEcCtD
Guanfacine—Vomiting—Topotecan—ovarian cancer	0.00134	0.00189	CcSEcCtD
Guanfacine—Malaise—Paclitaxel—ovarian cancer	0.00134	0.00189	CcSEcCtD
Guanfacine—Vertigo—Paclitaxel—ovarian cancer	0.00133	0.00188	CcSEcCtD
Guanfacine—Syncope—Paclitaxel—ovarian cancer	0.00133	0.00187	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00133	0.00187	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—ovarian cancer	0.00133	0.00187	CcSEcCtD
Guanfacine—Rash—Topotecan—ovarian cancer	0.00133	0.00187	CcSEcCtD
Guanfacine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00133	0.00187	CcSEcCtD
Guanfacine—Dermatitis—Topotecan—ovarian cancer	0.00133	0.00187	CcSEcCtD
Guanfacine—Headache—Topotecan—ovarian cancer	0.00132	0.00186	CcSEcCtD
Guanfacine—Palpitations—Paclitaxel—ovarian cancer	0.00131	0.00185	CcSEcCtD
Guanfacine—Vomiting—Melphalan—ovarian cancer	0.00131	0.00185	CcSEcCtD
Guanfacine—Immune system disorder—Docetaxel—ovarian cancer	0.0013	0.00184	CcSEcCtD
Guanfacine—Loss of consciousness—Paclitaxel—ovarian cancer	0.0013	0.00184	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—ovarian cancer	0.0013	0.00184	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—ovarian cancer	0.0013	0.00183	CcSEcCtD
Guanfacine—Rash—Melphalan—ovarian cancer	0.0013	0.00183	CcSEcCtD
Guanfacine—Dermatitis—Melphalan—ovarian cancer	0.0013	0.00183	CcSEcCtD
Guanfacine—Asthenia—Vinorelbine—ovarian cancer	0.00129	0.00182	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00129	0.00181	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00129	0.00181	CcSEcCtD
Guanfacine—Convulsion—Paclitaxel—ovarian cancer	0.00129	0.00181	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—ovarian cancer	0.00128	0.00181	CcSEcCtD
Guanfacine—Hypertension—Paclitaxel—ovarian cancer	0.00128	0.00181	CcSEcCtD
Guanfacine—Alopecia—Docetaxel—ovarian cancer	0.00128	0.0018	CcSEcCtD
Guanfacine—Pruritus—Vinorelbine—ovarian cancer	0.00127	0.00179	CcSEcCtD
Guanfacine—Arthralgia—Paclitaxel—ovarian cancer	0.00126	0.00178	CcSEcCtD
Guanfacine—Myalgia—Paclitaxel—ovarian cancer	0.00126	0.00178	CcSEcCtD
Guanfacine—Chest pain—Paclitaxel—ovarian cancer	0.00126	0.00178	CcSEcCtD
Guanfacine—Anxiety—Paclitaxel—ovarian cancer	0.00126	0.00177	CcSEcCtD
Guanfacine—Nausea—Topotecan—ovarian cancer	0.00125	0.00176	CcSEcCtD
Guanfacine—Discomfort—Paclitaxel—ovarian cancer	0.00125	0.00176	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00124	0.00175	CcSEcCtD
Guanfacine—Dry mouth—Paclitaxel—ovarian cancer	0.00124	0.00174	CcSEcCtD
Guanfacine—Diarrhoea—Vinorelbine—ovarian cancer	0.00123	0.00174	CcSEcCtD
Guanfacine—Dysgeusia—Docetaxel—ovarian cancer	0.00123	0.00174	CcSEcCtD
Guanfacine—Nausea—Melphalan—ovarian cancer	0.00122	0.00172	CcSEcCtD
Guanfacine—Confusional state—Paclitaxel—ovarian cancer	0.00122	0.00172	CcSEcCtD
Guanfacine—Asthma—Epirubicin—ovarian cancer	0.00122	0.00172	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—ovarian cancer	0.00122	0.00172	CcSEcCtD
Guanfacine—Oedema—Paclitaxel—ovarian cancer	0.00121	0.00171	CcSEcCtD
Guanfacine—Muscle spasms—Docetaxel—ovarian cancer	0.00121	0.0017	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.0012	0.0017	CcSEcCtD
Guanfacine—ADRA2A—uterine cervix—ovarian cancer	0.00119	0.0365	CbGeAlD
Guanfacine—Shock—Paclitaxel—ovarian cancer	0.00119	0.00168	CcSEcCtD
Guanfacine—Dizziness—Vinorelbine—ovarian cancer	0.00119	0.00168	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00119	0.00168	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00119	0.00168	CcSEcCtD
Guanfacine—Tachycardia—Paclitaxel—ovarian cancer	0.00118	0.00167	CcSEcCtD
Guanfacine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00117	0.00165	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00115	0.00162	CcSEcCtD
Guanfacine—Vomiting—Vinorelbine—ovarian cancer	0.00114	0.00161	CcSEcCtD
Guanfacine—ADRA2A—decidua—ovarian cancer	0.00114	0.0348	CbGeAlD
Guanfacine—Rash—Vinorelbine—ovarian cancer	0.00114	0.0016	CcSEcCtD
Guanfacine—Dermatitis—Vinorelbine—ovarian cancer	0.00113	0.0016	CcSEcCtD
Guanfacine—Hypotension—Paclitaxel—ovarian cancer	0.00113	0.00159	CcSEcCtD
Guanfacine—Headache—Vinorelbine—ovarian cancer	0.00113	0.00159	CcSEcCtD
Guanfacine—Syncope—Docetaxel—ovarian cancer	0.00113	0.00159	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—ovarian cancer	0.00113	0.00159	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—ovarian cancer	0.00113	0.00159	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—ovarian cancer	0.00112	0.00158	CcSEcCtD
Guanfacine—Palpitations—Docetaxel—ovarian cancer	0.00111	0.00157	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—ovarian cancer	0.00111	0.00156	CcSEcCtD
Guanfacine—Loss of consciousness—Docetaxel—ovarian cancer	0.00111	0.00156	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.0011	0.00155	CcSEcCtD
Guanfacine—Insomnia—Paclitaxel—ovarian cancer	0.0011	0.00154	CcSEcCtD
Guanfacine—Convulsion—Docetaxel—ovarian cancer	0.00109	0.00154	CcSEcCtD
Guanfacine—Paraesthesia—Paclitaxel—ovarian cancer	0.00109	0.00153	CcSEcCtD
Guanfacine—Hypertension—Docetaxel—ovarian cancer	0.00109	0.00153	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—ovarian cancer	0.00109	0.00153	CcSEcCtD
Guanfacine—Dyspnoea—Paclitaxel—ovarian cancer	0.00108	0.00152	CcSEcCtD
Guanfacine—ADRA2A—endometrium—ovarian cancer	0.00108	0.033	CbGeAlD
Guanfacine—CYP2C19—vagina—ovarian cancer	0.00108	0.0329	CbGeAlD
Guanfacine—Somnolence—Paclitaxel—ovarian cancer	0.00108	0.00152	CcSEcCtD
Guanfacine—Myalgia—Docetaxel—ovarian cancer	0.00107	0.00151	CcSEcCtD
Guanfacine—Arthralgia—Docetaxel—ovarian cancer	0.00107	0.00151	CcSEcCtD
Guanfacine—Chest pain—Docetaxel—ovarian cancer	0.00107	0.00151	CcSEcCtD
Guanfacine—Nausea—Vinorelbine—ovarian cancer	0.00107	0.00151	CcSEcCtD
Guanfacine—Dyspepsia—Paclitaxel—ovarian cancer	0.00107	0.0015	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—ovarian cancer	0.00106	0.00149	CcSEcCtD
Guanfacine—Decreased appetite—Paclitaxel—ovarian cancer	0.00105	0.00148	CcSEcCtD
Guanfacine—Dry mouth—Docetaxel—ovarian cancer	0.00105	0.00148	CcSEcCtD
Guanfacine—Fatigue—Paclitaxel—ovarian cancer	0.00104	0.00147	CcSEcCtD
Guanfacine—Sweating—Epirubicin—ovarian cancer	0.00104	0.00147	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—ovarian cancer	0.00104	0.00147	CcSEcCtD
Guanfacine—Constipation—Paclitaxel—ovarian cancer	0.00104	0.00146	CcSEcCtD
Guanfacine—Confusional state—Docetaxel—ovarian cancer	0.00103	0.00146	CcSEcCtD
Guanfacine—Oedema—Docetaxel—ovarian cancer	0.00103	0.00145	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—ovarian cancer	0.00103	0.00144	CcSEcCtD
Guanfacine—Shock—Docetaxel—ovarian cancer	0.00101	0.00142	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—ovarian cancer	0.001	0.00142	CcSEcCtD
Guanfacine—Tachycardia—Docetaxel—ovarian cancer	0.001	0.00141	CcSEcCtD
Guanfacine—ADRA2A—gonad—ovarian cancer	0.001	0.0306	CbGeAlD
Guanfacine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000998	0.00141	CcSEcCtD
Guanfacine—ADRA2A—uterus—ovarian cancer	0.000995	0.0304	CbGeAlD
Guanfacine—Bradycardia—Epirubicin—ovarian cancer	0.000992	0.0014	CcSEcCtD
Guanfacine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00099	0.0014	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—ovarian cancer	0.000977	0.00138	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000976	0.00138	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—ovarian cancer	0.000963	0.00136	CcSEcCtD
Guanfacine—Hypotension—Docetaxel—ovarian cancer	0.000959	0.00135	CcSEcCtD
Guanfacine—Abdominal pain—Paclitaxel—ovarian cancer	0.000957	0.00135	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—ovarian cancer	0.000939	0.00132	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000935	0.00132	CcSEcCtD
Guanfacine—Insomnia—Docetaxel—ovarian cancer	0.000928	0.00131	CcSEcCtD
Guanfacine—CYP2C9—female reproductive system—ovarian cancer	0.000923	0.0282	CbGeAlD
Guanfacine—Paraesthesia—Docetaxel—ovarian cancer	0.000922	0.0013	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—ovarian cancer	0.000918	0.00129	CcSEcCtD
Guanfacine—Dyspnoea—Docetaxel—ovarian cancer	0.000915	0.00129	CcSEcCtD
Guanfacine—Somnolence—Docetaxel—ovarian cancer	0.000912	0.00129	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—ovarian cancer	0.000911	0.00128	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—ovarian cancer	0.000909	0.00128	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—ovarian cancer	0.000904	0.00127	CcSEcCtD
Guanfacine—Dyspepsia—Docetaxel—ovarian cancer	0.000903	0.00127	CcSEcCtD
Guanfacine—ADRA2A—female reproductive system—ovarian cancer	0.000894	0.0273	CbGeAlD
Guanfacine—Decreased appetite—Docetaxel—ovarian cancer	0.000892	0.00126	CcSEcCtD
Guanfacine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000892	0.00126	CcSEcCtD
Guanfacine—Fatigue—Docetaxel—ovarian cancer	0.000885	0.00125	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—ovarian cancer	0.00088	0.00124	CcSEcCtD
Guanfacine—Constipation—Docetaxel—ovarian cancer	0.000878	0.00124	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—ovarian cancer	0.000869	0.00122	CcSEcCtD
Guanfacine—Asthenia—Paclitaxel—ovarian cancer	0.000869	0.00122	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—ovarian cancer	0.000861	0.00121	CcSEcCtD
Guanfacine—Pruritus—Paclitaxel—ovarian cancer	0.000857	0.00121	CcSEcCtD
Guanfacine—Feeling abnormal—Docetaxel—ovarian cancer	0.000846	0.00119	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—ovarian cancer	0.000843	0.00119	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—ovarian cancer	0.000841	0.00118	CcSEcCtD
Guanfacine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000839	0.00118	CcSEcCtD
Guanfacine—Tension—Epirubicin—ovarian cancer	0.000832	0.00117	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—ovarian cancer	0.000831	0.00117	CcSEcCtD
Guanfacine—Diarrhoea—Paclitaxel—ovarian cancer	0.000829	0.00117	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—ovarian cancer	0.000824	0.00116	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—ovarian cancer	0.000816	0.00115	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—ovarian cancer	0.000814	0.00115	CcSEcCtD
Guanfacine—ADRA2A—female gonad—ovarian cancer	0.000814	0.0249	CbGeAlD
Guanfacine—Abdominal pain—Docetaxel—ovarian cancer	0.000811	0.00114	CcSEcCtD
Guanfacine—ADRA2A—vagina—ovarian cancer	0.000809	0.0247	CbGeAlD
Guanfacine—Dizziness—Paclitaxel—ovarian cancer	0.000801	0.00113	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—ovarian cancer	0.000799	0.00113	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—ovarian cancer	0.000797	0.00112	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000787	0.00111	CcSEcCtD
Guanfacine—Agitation—Epirubicin—ovarian cancer	0.00078	0.0011	CcSEcCtD
Guanfacine—Tension—Doxorubicin—ovarian cancer	0.00077	0.00109	CcSEcCtD
Guanfacine—Vomiting—Paclitaxel—ovarian cancer	0.00077	0.00108	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—ovarian cancer	0.000769	0.00108	CcSEcCtD
Guanfacine—Malaise—Epirubicin—ovarian cancer	0.000765	0.00108	CcSEcCtD
Guanfacine—Rash—Paclitaxel—ovarian cancer	0.000764	0.00108	CcSEcCtD
Guanfacine—Dermatitis—Paclitaxel—ovarian cancer	0.000763	0.00107	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—ovarian cancer	0.000762	0.00107	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—ovarian cancer	0.000762	0.00107	CcSEcCtD
Guanfacine—Syncope—Epirubicin—ovarian cancer	0.000761	0.00107	CcSEcCtD
Guanfacine—Headache—Paclitaxel—ovarian cancer	0.000759	0.00107	CcSEcCtD
Guanfacine—Hypersensitivity—Docetaxel—ovarian cancer	0.000756	0.00107	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—ovarian cancer	0.000755	0.00106	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—ovarian cancer	0.00075	0.00106	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—ovarian cancer	0.000746	0.00105	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—ovarian cancer	0.00074	0.00104	CcSEcCtD
Guanfacine—Asthenia—Docetaxel—ovarian cancer	0.000736	0.00104	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—ovarian cancer	0.000735	0.00104	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—ovarian cancer	0.000732	0.00103	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000728	0.00103	CcSEcCtD
Guanfacine—Pruritus—Docetaxel—ovarian cancer	0.000726	0.00102	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—ovarian cancer	0.000722	0.00102	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—ovarian cancer	0.000722	0.00102	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—ovarian cancer	0.000722	0.00102	CcSEcCtD
Guanfacine—ADRA2A—testis—ovarian cancer	0.000722	0.0221	CbGeAlD
Guanfacine—Agitation—Doxorubicin—ovarian cancer	0.000721	0.00102	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—ovarian cancer	0.00072	0.00101	CcSEcCtD
Guanfacine—Nausea—Paclitaxel—ovarian cancer	0.000719	0.00101	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—ovarian cancer	0.000714	0.00101	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—ovarian cancer	0.000708	0.000997	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—ovarian cancer	0.000706	0.000995	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—ovarian cancer	0.000705	0.000994	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—ovarian cancer	0.000704	0.000992	CcSEcCtD
Guanfacine—CYP3A4—female reproductive system—ovarian cancer	0.000704	0.0215	CbGeAlD
Guanfacine—Diarrhoea—Docetaxel—ovarian cancer	0.000702	0.00099	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—ovarian cancer	0.000698	0.000984	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—ovarian cancer	0.000694	0.000977	CcSEcCtD
Guanfacine—Oedema—Epirubicin—ovarian cancer	0.000692	0.000976	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00069	0.000972	CcSEcCtD
Guanfacine—Shock—Epirubicin—ovarian cancer	0.000681	0.00096	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—ovarian cancer	0.00068	0.000958	CcSEcCtD
Guanfacine—Dizziness—Docetaxel—ovarian cancer	0.000679	0.000956	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—ovarian cancer	0.000678	0.000955	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—ovarian cancer	0.000676	0.000952	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000669	0.000943	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—ovarian cancer	0.000668	0.000942	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—ovarian cancer	0.000668	0.000942	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—ovarian cancer	0.000668	0.000942	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—ovarian cancer	0.000666	0.000938	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—ovarian cancer	0.00066	0.00093	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—ovarian cancer	0.000654	0.000921	CcSEcCtD
Guanfacine—Vomiting—Docetaxel—ovarian cancer	0.000653	0.00092	CcSEcCtD
Guanfacine—Rash—Docetaxel—ovarian cancer	0.000647	0.000912	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—ovarian cancer	0.000647	0.000912	CcSEcCtD
Guanfacine—Dermatitis—Docetaxel—ovarian cancer	0.000647	0.000911	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—ovarian cancer	0.000646	0.00091	CcSEcCtD
Guanfacine—Headache—Docetaxel—ovarian cancer	0.000643	0.000906	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—ovarian cancer	0.000641	0.000903	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000631	0.000889	CcSEcCtD
Guanfacine—Shock—Doxorubicin—ovarian cancer	0.00063	0.000888	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—ovarian cancer	0.000626	0.000882	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—ovarian cancer	0.000625	0.000881	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—ovarian cancer	0.000622	0.000876	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000619	0.000873	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—ovarian cancer	0.000617	0.00087	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—ovarian cancer	0.000615	0.000867	CcSEcCtD
Guanfacine—Nausea—Docetaxel—ovarian cancer	0.00061	0.000859	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—ovarian cancer	0.000609	0.000859	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—ovarian cancer	0.000602	0.000848	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—ovarian cancer	0.000599	0.000843	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—ovarian cancer	0.000597	0.000841	CcSEcCtD
Guanfacine—Constipation—Epirubicin—ovarian cancer	0.000592	0.000834	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000584	0.000822	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—ovarian cancer	0.000579	0.000816	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—ovarian cancer	0.000575	0.00081	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—ovarian cancer	0.000571	0.000805	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—ovarian cancer	0.00057	0.000804	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—ovarian cancer	0.000569	0.000802	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000566	0.000798	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—ovarian cancer	0.000564	0.000795	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—ovarian cancer	0.000557	0.000785	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—ovarian cancer	0.000552	0.000778	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—ovarian cancer	0.000548	0.000772	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—ovarian cancer	0.000547	0.000771	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000528	0.000744	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000524	0.000738	CcSEcCtD
Guanfacine—ADRA2A—lymph node—ovarian cancer	0.000523	0.016	CbGeAlD
Guanfacine—Hypersensitivity—Epirubicin—ovarian cancer	0.00051	0.000719	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—ovarian cancer	0.000506	0.000714	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—ovarian cancer	0.000497	0.0007	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—ovarian cancer	0.00049	0.00069	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—ovarian cancer	0.000474	0.000667	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000472	0.000665	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—ovarian cancer	0.00046	0.000648	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—ovarian cancer	0.000458	0.000645	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—ovarian cancer	0.000453	0.000639	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—ovarian cancer	0.00044	0.00062	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—ovarian cancer	0.000438	0.000618	CcSEcCtD
Guanfacine—Rash—Epirubicin—ovarian cancer	0.000436	0.000615	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—ovarian cancer	0.000436	0.000615	CcSEcCtD
Guanfacine—Headache—Epirubicin—ovarian cancer	0.000434	0.000611	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—ovarian cancer	0.000424	0.000597	CcSEcCtD
Guanfacine—Nausea—Epirubicin—ovarian cancer	0.000411	0.000579	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—ovarian cancer	0.000407	0.000574	CcSEcCtD
Guanfacine—Rash—Doxorubicin—ovarian cancer	0.000404	0.000569	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—ovarian cancer	0.000404	0.000569	CcSEcCtD
Guanfacine—Headache—Doxorubicin—ovarian cancer	0.000401	0.000565	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—ovarian cancer	0.00038	0.000536	CcSEcCtD
